anonymous
Guest
anonymous
Guest
So what’s the status? Has anyone been let go yet? How long will it take to resubmit?
Here’s an idea! We should all become outgoing call center operators!Sorry to hear that salespeople were let go. Nothing ventured, nothing gained.
MF, time to go back to managing computer sales people. Hope you can hire another elite team. Karma.
A great future? A blockbuster drug?What’s left at Tricida?
Time to call Factor8!A great future? A blockbuster drug?
Jesus - give it a rest. You must be one miserable dude with zero life to continue to troll this site. We get it, you have a hard on for MF - f’ing get over it and move on. Your excitement over seeing him and others crash is pathetic and disturbing.Salaries? LOL
They are done(they bring the organization)
Another setback
Just announced massive layoffs
But MF’er still building an elite sales team
I’m trying to figure out who would have such a hard on for M. Did he fire anyone at OPKO?Jesus - give it a rest. You must be one miserable dude with zero life to continue to troll this site. We get it, you have a hard on for MF - f’ing get over it and move on. Your excitement over seeing him and others crash is pathetic and disturbing.
Accurate but, doesn’t matter now. By the time they launch, he’ll be gone.Good product if it ever gets approved but, the company will never be a success until the CEO GK is ousted. He has some talent in research but is clueless and doesn’t care to learn the commercial side of the business. If you get the chance to launch the drug in a few years, make sure it isn’t with a CEO who doesn’t understand life beyond a test tube and isn’t smart enough to listen to those he hires with expertise in areas he doesn’t know. Arrogant and zero EQ. He thinks it’s “Socratic” leadership but instead he’s just a narcissist plain and simple.
I’m trying to figure out who would have such a hard on for M. Did he fire anyone at OPKO?
A page out of the OPKO book! The former OPKO peeps must smelled the stench immediately.Purely an R&D play. Zero understanding of need for commercial team. Delay not good for investors or patients but in hindsight, an advantage for those let go. They can move on to organizations that don’t naively or arrogantly believe the product will market, create access and sell itself.